- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Innate Pharma Stock (NASDAQ:IPHA), Quotes and News Summary
Innate Pharma Stock (NASDAQ: IPHA)
| Day Range1.98 - 2.1 | 52 Wk Range1.99 - 4.87 | Open / Close2.1 / 2 | Float / Outstanding- / 79.9M |
| Vol / Avg.14.8K / 8.1K | Mkt Cap159.8M | P/E- | 50d Avg. Price2.67 |
| Div / Yield- | Payout Ratio- | Total Float- | EPS- |
Earnings
see more| H1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.090 | ||||||
| REV | 49.881M |
| FY 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.650 | ||||||
| REV | 28.255M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Innate Pharma Questions & Answers
You can purchase shares of Innate Pharma (NASDAQ: IPHA) through any online brokerage.
Other companies in Innate Pharma’s space includes: Anixa Biosciences (NASDAQ:ANIX), Graphite Bio (NASDAQ:GRPH), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for Innate Pharma (NASDAQ: IPHA) was reported by Citigroup on Friday, September 16, 2022. The analyst firm set a price target for 12.00 expecting IPHA to rise to within 12 months (a possible 500.00% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Innate Pharma (NASDAQ: IPHA) is $2 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Innate Pharma.
Innate Pharma’s H1 earnings are confirmed for Thursday, September 15, 2022.
There is no upcoming split for Innate Pharma.
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.